Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- Natural Health Trends Corp. Announces Second Quarter and Six Months 2006 Results
Company reports net sales of $36.3 million, compared to $50.0 million for the second quarter a year ago, with a net loss of $2.8 million, or $0.34 per fully diluted share, compared to a net loss of $2.2 million, or $0.32 per fully diluted share, a year ago in the comparable quarter.
- Natural Health Trends Corp. Announces Second Quarter and Six Months 2006 Results
Company reports net sales of $36.3 million, compared to $50.0 million for the second quarter a year ago, with a net loss of $2.8 million, or $0.34 per fully diluted share, compared to a net loss of $2.2 million, or $0.32 per fully diluted share, a year ago in the comparable quarter.
- Redux Holdings Completes Acquisition of Controlling Interest of Naturade, Inc.
Company has successfully completed the acquisition of a controlling interest in Naturade, Inc. with Richard Munro stepping in as CEO of Naturade and Bill Stewart continuing in his role as President.
- Redux Holdings Completes Acquisition of Controlling Interest of Naturade, Inc.
Company has successfully completed the acquisition of a controlling interest in Naturade, Inc. with Richard Munro stepping in as CEO of Naturade and Bill Stewart continuing in his role as President.
- NIR Diagnostics and Shaklee Corporation finalize strategic alliance agreement
Company has announced that the previously announced strategic alliance transaction with Shaklee Corporation, under which NIR Diagnostics will utilize its non-invasive light-based technology to develop a prototype device for use in Shaklee's food supplement business, became effective on August 9, 2006, and that the initial payment of $2,000,000 due under the agreement has been paid by Shaklee to NIR Diagnostics.
- NIR Diagnostics and Shaklee Corporation finalize strategic alliance agreement
Company has announced that the previously announced strategic alliance transaction with Shaklee Corporation, under which NIR Diagnostics will utilize its non-invasive light-based technology to develop a prototype device for use in Shaklee's food supplement business, became effective on August 9, 2006, and that the initial payment of $2,000,000 due under the agreement has been paid by Shaklee to NIR Diagnostics.
- NIR Diagnostics and Shaklee Corporation finalize strategic alliance agreement
Company has announced that the previously announced strategic alliance transaction with Shaklee Corporation, under which NIR Diagnostics will utilize its non-invasive light-based technology to develop a prototype device for use in Shaklee's food supplement business, became effective on August 9, 2006, and that the initial payment of $2,000,000 due under the agreement has been paid by Shaklee to NIR Diagnostics.
- Zila, Inc. Announces Strategic Divestiture of Zila Nutraceuticals, Inc.
announced that it has signed a definitive agreement for the sale of all of the common stock of its Zila Nutraceuticals, Inc. subsidiary to NBTY, Inc., for a purchase price of up to $40.5 million with $37.5 million to be paid in cash at close and the remainder to be paid through an earn-out formula that is dependent upon the future performance of the business.
- Zila, Inc. Announces Strategic Divestiture of Zila Nutraceuticals, Inc.
announced that it has signed a definitive agreement for the sale of all of the common stock of its Zila Nutraceuticals, Inc. subsidiary to NBTY, Inc., for a purchase price of up to $40.5 million with $37.5 million to be paid in cash at close and the remainder to be paid through an earn-out formula that is dependent upon the future performance of the business.
- Lifeway Foods Inc. Reports Second Quarter and Six Month Results
Company reports revenues of $6.37 million, up 26% from last year's second quarter revenues of $5.07 million, with net income pf $750,044 in the second quarter of 2006 versus a net income of $556,845 in 2005.
- Lifeway Foods Inc. Reports Second Quarter and Six Month Results
Company reports revenues of $6.37 million, up 26% from last year's second quarter revenues of $5.07 million, with net income pf $750,044 in the second quarter of 2006 versus a net income of $556,845 in 2005.
- AMS Health Sciences, Inc. Announces Second Quarter 2006 Financial Results
Company reports a net profit from continuing operations for the second quarter 2006 of $32,617, or $0.01 per common (diluted) share, versus a net loss of $(769,446), or $(0.11) per common (diluted) share, for tue prior year period. Sales totaled $2.4 million for the quarter compared to sales of $3.5 million for the quarter ended June 30, 2005.
- AMS Health Sciences, Inc. Announces Second Quarter 2006 Financial Results
Company reports a net profit from continuing operations for the second quarter 2006 of $32,617, or $0.01 per common (diluted) share, versus a net loss of $(769,446), or $(0.11) per common (diluted) share, for tue prior year period. Sales totaled $2.4 million for the quarter compared to sales of $3.5 million for the quarter ended June 30, 2005.
- Natrol, Inc. Announces Second Quarter 2006 Earnings
Company reports net income of $0.1 million on net sales of $16.6 million for its second quarter ending June 30, 2006, compared to net income of $0.3 million for the second quarter of 2005 on net sales of $19.6 million. Company attributes revenue decline to lack of new product introduction during the period.
- Natrol, Inc. Announces Second Quarter 2006 Earnings
Company reports net income of $0.1 million on net sales of $16.6 million for its second quarter ending June 30, 2006, compared to net income of $0.3 million for the second quarter of 2005 on net sales of $19.6 million. Company attributes revenue decline to lack of new product introduction during the period.
- NutraCea Announces Record 2nd Quarter Results
Company reports revenues of $4,166,182, compared to total revenues of $299,237 for the second quarter of 2005, with net income of $399,434 or $0.01 per share for the second quarter of 2006, compared to a net loss of $(1,800,084), or $(0.05) per share in 2005.
- NutraCea Announces Record 2nd Quarter Results
Company reports revenues of $4,166,182, compared to total revenues of $299,237 for the second quarter of 2005, with net income of $399,434 or $0.01 per share for the second quarter of 2006, compared to a net loss of $(1,800,084), or $(0.05) per share in 2005.
- Vital Living Inc. Announces Second Quarter Results
Company reports net income of $401,000, or $0.00 basic and ($0.01) fully diluted loss per share, compared with a $492,000 loss, or $0.00 basic and fully diluted loss per share prior year.
- Vital Living Inc. Announces Second Quarter Results
Company reports net income of $401,000, or $0.00 basic and ($0.01) fully diluted loss per share, compared with a $492,000 loss, or $0.00 basic and fully diluted loss per share prior year.
- Forbes Medi-Tech Announces Second Quarter 2006 Results
Company reports revenues of $1.68 million for the three months ended June 30, 2006 compared to $1.28 million for the three months ended June 30, 2005, with a net loss of $0.17 per share for the three months ended June 30, 2006 compared to $0.09 per share loss for the three months ended June 30, 2005 ($6 million compared to $3.2 million for the same period last year).
- Forbes Medi-Tech Announces Second Quarter 2006 Results
Company reports revenues of $1.68 million for the three months ended June 30, 2006 compared to $1.28 million for the three months ended June 30, 2005, with a net loss of $0.17 per share for the three months ended June 30, 2006 compared to $0.09 per share loss for the three months ended June 30, 2005 ($6 million compared to $3.2 million for the same period last year).
- Forbes Medi-Tech Announces Second Quarter 2006 Results
Company reports revenues of $1.68 million for the three months ended June 30, 2006 compared to $1.28 million for the three months ended June 30, 2005, with a net loss of $0.17 per share for the three months ended June 30, 2006 compared to $0.09 per share loss for the three months ended June 30, 2005 ($6 million compared to $3.2 million for the same period last year).
- MGP Ingredients Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net income of $7,363,000, or $0.45 in basic earnings per share, for the fourth quarter, which ended June 30, 2006, compared to net income of $732,000, or $0.05 in basic earnings per share, for the fourth quarter of fiscal 2005, on sales of $90,338,000, an increase of 22 percent above sales of $73,949,000 in the prior year period.
- MGP Ingredients Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net income of $7,363,000, or $0.45 in basic earnings per share, for the fourth quarter, which ended June 30, 2006, compared to net income of $732,000, or $0.05 in basic earnings per share, for the fourth quarter of fiscal 2005, on sales of $90,338,000, an increase of 22 percent above sales of $73,949,000 in the prior year period.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Natrol's Prolab Business Poised for Growth; New Senior Marketing Teams Drive Prolab Business Growth
Company announces the appointment of senior marketing management for Prolab(R), Natrol's sports nutrition brand in the United States and the United Kingdom, as Eric Schick, Vice President of Marketing, and Gloria Reynolds, Director of Marketing, head the U.S. team, while Margaret Peet leads UK team along with Tony Gay, Business Development Manager.
- Natrol's Prolab Business Poised for Growth; New Senior Marketing Teams Drive Prolab Business Growth
Company announces the appointment of senior marketing management for Prolab(R), Natrol's sports nutrition brand in the United States and the United Kingdom, as Eric Schick, Vice President of Marketing, and Gloria Reynolds, Director of Marketing, head the U.S. team, while Margaret Peet leads UK team along with Tony Gay, Business Development Manager.
- Natrol's Prolab Business Poised for Growth; New Senior Marketing Teams Drive Prolab Business Growth
Company announces the appointment of senior marketing management for Prolab(R), Natrol's sports nutrition brand in the United States and the United Kingdom, as Eric Schick, Vice President of Marketing, and Gloria Reynolds, Director of Marketing, head the U.S. team, while Margaret Peet leads UK team along with Tony Gay, Business Development Manager.
- Natrol's Prolab Business Poised for Growth; New Senior Marketing Teams Drive Prolab Business Growth
Company announces the appointment of senior marketing management for Prolab(R), Natrol's sports nutrition brand in the United States and the United Kingdom, as Eric Schick, Vice President of Marketing, and Gloria Reynolds, Director of Marketing, head the U.S. team, while Margaret Peet leads UK team along with Tony Gay, Business Development Manager.
- BioGaia Sells Oil to Canada and The Middle East
Company has expanded its March 2006 agreement with Swiss pharmaceutical company Ferring Pharmaceuticals for an exclusive
license to sell BioGaia's probiotic drops to now include Canada and several Middle East countries.
- BioGaia Sells Oil to Canada and The Middle East
Company has expanded its March 2006 agreement with Swiss pharmaceutical company Ferring Pharmaceuticals for an exclusive
license to sell BioGaia's probiotic drops to now include Canada and several Middle East countries.
- BioGaia Sells Oil to Canada and The Middle East
Company has expanded its March 2006 agreement with Swiss pharmaceutical company Ferring Pharmaceuticals for an exclusive
license to sell BioGaia's probiotic drops to now include Canada and several Middle East countries.
- BioGaia Sells Oil to Canada and The Middle East
Company has expanded its March 2006 agreement with Swiss pharmaceutical company Ferring Pharmaceuticals for an exclusive
license to sell BioGaia's probiotic drops to now include Canada and several Middle East countries.
- BioGaia Sells Oil to Canada and The Middle East
Company has expanded its March 2006 agreement with Swiss pharmaceutical company Ferring Pharmaceuticals for an exclusive
license to sell BioGaia's probiotic drops to now include Canada and several Middle East countries.
- Herbalife Appoints New Vice President of Human Resources and Further Implements Global HR Strategy
Company announces the appointment of Robert Engelbrecht as vice president of human resources for the company's EMEA (Europe, Middle East and Africa) region, and the appointment of Takayuki Ikeda as director of human resources supporting the North Asia region.
- Herbalife Appoints New Vice President of Human Resources and Further Implements Global HR Strategy
Company announces the appointment of Robert Engelbrecht as vice president of human resources for the company's EMEA (Europe, Middle East and Africa) region, and the appointment of Takayuki Ikeda as director of human resources supporting the North Asia region.
- Herbalife Appoints New Vice President of Human Resources and Further Implements Global HR Strategy
Company announces the appointment of Robert Engelbrecht as vice president of human resources for the company's EMEA (Europe, Middle East and Africa) region, and the appointment of Takayuki Ikeda as director of human resources supporting the North Asia region.
- Herbalife Appoints New Vice President of Human Resources and Further Implements Global HR Strategy
Company announces the appointment of Robert Engelbrecht as vice president of human resources for the company's EMEA (Europe, Middle East and Africa) region, and the appointment of Takayuki Ikeda as director of human resources supporting the North Asia region.
- Frutarom Reports Second Quarter Results
Company reports sales of US$ 72.3 million, growth of 7.9%, compared with the same quarter of 2005, with gross profit of US$ 26.3 million compared with US$ 26.9 million, a decline of 2.4%.
- Frutarom Reports Second Quarter Results
Company reports sales of US$ 72.3 million, growth of 7.9%, compared with the same quarter of 2005, with gross profit of US$ 26.3 million compared with US$ 26.9 million, a decline of 2.4%.
- Lifeline Therapeutics, Inc. Announces Q4 and FY 2006 Financial and Operating Results
Company reports Q4 revenues of 1.1 million and a loss of $(1.6) million, or $(0.07) per share, compared to revenues of $2.3 million and a loss of $(2.8) million, or $(0.16) per share prior year.
- Lifeline Therapeutics, Inc. Announces Q4 and FY 2006 Financial and Operating Results
Company reports Q4 revenues of 1.1 million and a loss of $(1.6) million, or $(0.07) per share, compared to revenues of $2.3 million and a loss of $(2.8) million, or $(0.16) per share prior year.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
Boehringer Ingelheim and IdeaSphere Inc. have announced the sale of Boehringer Ingelheim's Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere
- Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
Boehringer Ingelheim and IdeaSphere Inc. have announced the sale of Boehringer Ingelheim's Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- Compound Solutions Announces CoQ10 Agreement with Premier Manufacturer in China
Company announces its agreement to represent Hangzhou Zhongmeihuadong Pharmaceutical (HZH) in CoQ10 distribution across North America and Europe.
- Compound Solutions Announces CoQ10 Agreement with Premier Manufacturer in China
Company announces its agreement to represent Hangzhou Zhongmeihuadong Pharmaceutical (HZH) in CoQ10 distribution across North America and Europe.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
VANCOUVER, Aug. 17 /CNW/ - Burcon NutraScience Corporation (TSX-V: BU) announces today that it has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. Linola is the trademark name of solin varieties, strains of flax, now being developed by Canada's Agricore United through a joint venture with CSIRO - the Commonwealth Scientific and Industrial Research Organization of Australia which developed the original strain in the early 1990's. The patent application, which is the subject of this announcement, was originally filed in November 2002. At that time, Burcon also filed applications, which are currently being reviewed, with the United States Patent and Trademark Office as well as internationally under the Patent Cooperation Treaty of the World Intellectual Property Organization. Burcon has committed to register this patent in some twenty European countries. As previously announced, Burcon already holds four U.S. patents over canola protein processing technology and canola protein isolate product uses. A number of Burcon's patent applications, including one which has already granted, are applicable to oilseeds and oilseed meals other than canola; including sunflower, soybean and even hemp seed. This is the first exclusively non-canola based technology over which Burcon has obtained patent protection. "Flax is an important oil seed crop which has seen strong growth in consumer awareness for its health benefits including omega 3 fatty acids, lignans and fibre," stated Johann F. Tergesen, Burcon's President & COO who added, "Burcon will continue to devote some of its resources to exploring opportunities beyond its core canola protein isolate technology."
About Burcon NutraScience
Burcon is a research and development company developing a portfolio of composition, application, and process patents around its plant protein extraction and purification technology. The goal of Burcon's research is to develop its patented process to utilize inexpensive oilseed meals for the production of purified plant proteins that exhibit valuable nutritional, functional or nutraceutical profiles. Burcon, in conjunction with Archer Daniels Midland, is currently focusing its efforts on developing the world's first commercial canola proteins, Puratein(R) and Supertein(TM). Canola, recognized for its nutritional qualities, is the second-largest oilseed crop in the world after soybeans. Burcon's goal is to develop Puratein and Supertein to participate with soy, dairy, and egg proteins in the expanding multi-billion-dollar protein ingredient market, with potential uses in prepared foods, nutritional supplements, and personal care products.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our products ,statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal," "intend," "believes" and "potential" and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized. |